Anticonvulsants in the treatment of anxiety - an alternative treatment option?

被引:0
作者
Zwanzger, P.
Eser, D.
Rupprecht, R.
机构
[1] Univ Klinikum Munster, Klin Psychiat & Psychotherapie, D-49149 Munster, Germany
[2] Univ Munich, Klin Psychiat & Psychotherapie, D-80539 Munich, Germany
来源
NERVENARZT | 2007年 / 78卷 / 11期
关键词
panic disorder; generalized anxiety disorder; social phobia; pharmacotherapy; anticonvulsants; PANIC DISORDER; DOUBLE-BLIND; SOCIAL PHOBIA; OPEN-LABEL; PREGABALIN; TIAGABINE; EFFICACY; MULTICENTER; TRIAL; GABAPENTIN;
D O I
10.1007/s00115-007-2361-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
According to epidemiological studies anxiety disorders are among the most frequent psychiatric disorders. Depending on the diagnosis and severity, both cognitive behaviour therapy and pharmacological approaches are applied. In today's drug therapy antidepressants are the standard first-line treatment for most anxiety disorders, and enzodiazepines for the treatment of acute anxiety states. However, many patients do not respond to the first drug prescribed, prove to have conditions that are resistant to therapy or complain of side effects. There is therefore still a need for new medicamentous treatment strategies. There are numerous studies suggesting that anticonvulsants also have potentially anxiolytic properties and might therefore be an alternative treatment option in anxiety syndromes. This article gives an overview of investigations to date on the effects of various anticonvulsants in panic disorder, generalized anxiety disorder and social phobia.
引用
收藏
页码:1274 / +
页数:6
相关论文
共 43 条
  • [1] [Anonymous], BIOL PSYCHIAT
  • [2] Ballenger JC, 1998, MED PSYCHIATRY, V10, P1
  • [3] BALLENGER JC, 1988, ARCH GEN PSYCHIAT, V45, P413
  • [4] Defining response and remission in anxiety disorders: Toward an integrated approach
    Bandelow, Borwin
    [J]. CNS SPECTRUMS, 2006, 11 (10) : 21 - 28
  • [5] Barlow D., 2002, Anxiety and disorders: The nature and treatment of anxiety and panic
  • [6] BARLOW DH, 2002, ANXIETY DISORDERS RE
  • [7] The effects of vigabatrin on electrophysiology and visual fields in epileptics: A controlled study with a discussion of possible mechanisms
    Comaish I.F.
    Gorman C.
    Brimlow G.M.
    Barber C.
    Orr G.M.
    Galloway N.R.
    [J]. Documenta Ophthalmologica, 2002, 104 (2) : 195 - 212
  • [8] Tiagabine for the treatment of anxiety
    Crane, D
    [J]. DEPRESSION AND ANXIETY, 2003, 18 (01) : 51 - 52
  • [9] A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder
    Feltner, DE
    Crockatt, JG
    Dubovsky, SJ
    Cohn, CK
    Shrivastava, RK
    Targum, SD
    Liu-Dumaw, M
    Carter, CM
    Pande, AC
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (03) : 240 - 249
  • [10] Gallinat J, 1999, NERVENARZT, V70, P206, DOI 10.1007/s001150050424